Business
Why has the Telix (ASX:TXL) share price shot up 5% today?
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher after the company announced a new phase in its drug trials. The company confirmed it will proceed with the Phase III of ProstACT study for its TLX591 drug, a prostate cancer treatment.
The company also advised this morning that it has entered into a commercialisation and partnership agreement with DuChemBio, a leading South Korean radiopharmaceutical company.
At the time of writing, the Telix share price has surged up 5% to $4.20.
About the Phase III testing
Telix recently met with the United States Food and Drug Administration (FDA) to discuss the company’s planned Phase III ProstACT trial for TLX591. Today’s announcement is the result of that meeting.
The…
-
General22 hours agoSearch underway for missing boat off South Australia’s Cape Jaffa
-
Noosa News23 hours agoQueensland coroner investigates ‘extremely unusual’ deaths of premature twin boys
-
Noosa News9 hours agoThe Best Things to Do in Brisbane This New Year’s Eve
-
General8 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle